Follow-The-Filings

Security

Candel Therapeutics Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

8 owners 5 new max 0.0% (Vanguard Group Inc.)

owners 8
max % 0.0%
tracked value $20M
qoq N 5 A 1 R 1

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 2,305,060 $13M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% New 0.0% 1,060,086 $5M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 99,200 $560 hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% New 0.0% 107,211 $525 hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 72,666 $356 hist
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% New 0.0% 43,208 $212 hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% New 0.0% 18,028 $88 hist
Renaissance Technologies LLC 2026 Q1 0.0% New 0.0% 12,780 $63 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue
Gross profit
Gross margin
Net income -$37.94M -$55.18M -$38.18M
Net margin

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $36.8M $103.8M $121.39M
Total non-current assets * $4.4M $3.06M $3.81M
Total assets $41.2M $106.87M $125.2M
Total current liabilities $14.18M $37.53M $9M
Total non-current liabilities * $14.27M $3.01M $64.28M
Total equity $12.74M $66.33M $51.92M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$34.24M -$27.02M -$38.31M
Cash from investing -$280,000 -$16,000 -$560,000
Cash from financing -$121,000 $94.28M $56.1M
Net change in cash -$34.64M $67.24M $17.23M

ownership over time

filing count by report period · click a bar for that quarter’s holders